Sarcoma  >>  dasatinib  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dasatinib / Generic mfg.
NCT00423735: Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

Completed
2
64
Canada, US, RoW
Dasatinib, BMS-354825, Sprycel, Pharmacological Study
National Cancer Institute (NCI), Radiation Therapy Oncology Group, NRG Oncology
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Neoplasm
03/11
09/18
SAKK 56/07, NCT00568750 / 2007-002047-24: Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors

Completed
2
47
Europe
dasatinib, Sprycel
Swiss Group for Clinical Cancer Research
Gastrointestinal Stromal Tumor
01/12
05/18
NCT00464620: Trial of Dasatinib in Advanced Sarcomas

Completed
2
366
US
Dasatinib
Sarcoma Alliance for Research through Collaboration, Bristol-Myers Squibb
Rhabdomyosarcoma, Malignant Peripheral Nerve Sheath Tumors, Chondrosarcoma, Sarcoma, Ewing's, Sarcoma, Alveolar Soft Part, Chordoma, Epithelioid Sarcoma, Giant Cell Tumor of Bone, Hemangiopericytoma, Gastrointestinal Stromal Tumor (GIST)
12/16
05/17
NCT00788125: Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Terminated
1/2
7
US
carboplatin, dasatinib, etoposide phosphate, ifosfamide, microarray analysis, western blotting, immunohistochemistry staining method, laboratory biomarker analysis, therapeutic conventional surgery, radiation therapy
City of Hope Medical Center, National Cancer Institute (NCI)
Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Kidney Cancer, Liver Cancer, Lymphoma, Neuroblastoma, Ovarian Cancer, Sarcoma, Testicular Germ Cell Tumor, Unspecified Childhood Solid Tumor, Protocol Specific
04/10
07/22
NCT03041701: Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma

Terminated
1/2
14
US
Dasatinib, Sprycel, Ganitumab, Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479
National Cancer Institute (NCI)
Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal
09/21
10/21

Download Options